
276 Promising activity with capecitabine and mitomycin C (MMC) as third line therapy for patients with metastatic colorectal cancer (MCRC) resistant to fluorouracil (5-FU) and irinotecan: results of a phase II study
J.L.B. Dickson, S. Rao, M.E. Hill, T.J. Price, A.R. Norman, J. Oates, D. CunninghamVolume:
1
Année:
2003
Langue:
english
DOI:
10.1016/s1359-6349(03)90309-0
Fichier:
PDF, 168 KB
english, 2003